IMR Press / RCM / Special Issues / 1631239208617

Structural Heart Interventions

Submission deadline: 30 April 2022
Special Issue Editor
  • Jinnette D. Abbott, MD
    Division of Cardiology, Department of Medicine, Brown University, Providence, Rhode Island, USA
    Interests: Congenital heart defects; Coronary artery disease; Heart rhythm disorders; Heart failure
Special Issue Information

Dear Colleagues,


Structural heart disease encompasses congenital and acquired noncoronary cardiac pathologies which can present throughout the lifespan. In adult patients, there has been a shift in management from predominantly surgical to a minimally invasive catheter-based approach. This has expanded the population of patients eligible for treatment by offering patients at high or prohibitive risk for surgery an option. In addition, many catheter-based interventions are supported by randomized and observational studies demonstrating the safety and efficacy of the devices and short patient recovery times. Today, many types of procedures are performed in the outpatient or observation setting. Transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) has supplanted surgical AVR in all but the lowest surgical risk patients including those indicated for a mechanical prosthesis, and those requiring additional valvular, aortic, or coronary procedures. TAVR can be appropriate in special populations such as patients with bicuspid aortic valves and is often chosen in patients with a failed bioprosthesis, termed a valve-on-valve procedure. While the femoral artery is the main access for TAVR, alternative access options have been developed for patients with severe peripheral vascular disease that have replaced the transapical approach, including trans-axillary, trans-cava, and trans-carotid.  Whether TAVR can improve outcomes in symptomatic patients with moderate AS is under investigation. Paravalvular leaks (PVL), which complicate both catheter-based and surgical valves, can result in complications such as heart failure and hemolysis and often require treatment. Transcatheter PVL closure techniques and devices have improved and expanded over the past two decades and are the preferred method of closure in many centers. The regurgitant valvular disease has been more challenging to treat with a percutaneous approach. Transcatheter mitral valve repair (TMVR) with the MitraClip has a role in the management of certain populations with severe MR. Patient selection based on clinical and anatomic factors, and optimization of medical therapy are important considerations with this device. Several devices or under development for mitral and tricuspid regurgitation may expand minimally invasive options for patients. This issue of the journal provides focused reviews on the current and future state of adult percutaneous structural heart interventions.

Prof. Dr. Jinnette D. Abbott

Guest Editor

Structural heart disease
Aortic stenosis
Bicuspid aortic valve
Vascular access
Paravalvular leak
Mitral regurgitation
Minimally invasive
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (8 Papers)
Back to top